Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
wentian zhang[Author]
(43 results)?
Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance.
J Med Chem. 2024 May 10. doi: 10.1021/acs.jmedchem.4c00144. Online ahead of print.
J Med Chem. 2024.
PMID: 38727048
Dual-targeting tumor cells hybrids derived from Pt(IV) species and NF-κB inhibitors enables cancer therapy through mitochondrial dysfunction and ER stress and overcomes cisplatin resistance.
Wang M, Li G, Jiang G, Cai J, Zhong W, Huang R, Liu Z, Huang X, Wang H.
Wang M, et al. Among authors: zhong w.
Eur J Med Chem. 2024 Feb 15;266:116095. doi: 10.1016/j.ejmech.2023.116095. Epub 2023 Dec 25.
Eur J Med Chem. 2024.
PMID: 38215589
Item in Clipboard
Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment.
Huang X, Chen Y, Zhong W, Liu Z, Zhang H, Zhang B, Wang H.
Huang X, et al. Among authors: zhong w.
Eur J Med Chem. 2022 Dec 15;244:114817. doi: 10.1016/j.ejmech.2022.114817. Epub 2022 Oct 4.
Eur J Med Chem. 2022.
PMID: 36252396
Item in Clipboard
Cite
Cite